Item 9 Labs Corp. announced that its new 20,000 square-foot cultivation and lab facility in Pahrump, N.V., is nearing completion and expected to be fully operational by the end of 2022.
The master development and expansion of the Nevada Facility began in early 2019 and had been advancing quickly, especially in the past year. Currently, Item 9 Labs Corp. is awaiting the water and electrical connections to be completed as well as the installation of air conditioning units and backup generators. The company is working with the City of Pahrump and Nye County to finalize the Certificate of Occupancy.
"Our Nevada cultivation and lab facility was strategically developed to ensure full optimization and efficiency throughout," said Chase Herschmann, director of business development at Item 9 Labs Corp., adding that the company's experienced team has spearheaded the build and expansion of multiple cultivation sites across the North America, along with its current master site expansion that is underway in Coolidge, Ariz.
He continued, "Our construction team works hand-in-hand with operations to ensure our facilities are developed with our strategic processes for every function, from cultivation to extraction and production top of mind."
Once the cultivation and lab facility is finalized this coming fall, it will include 4,450 square feet of operations space for flowers, 990 square feet of vegetation space, 400 square feet for clones, and 300 square feet for dry curing, and 615 square feet for genetics. The facility also houses more than 2,500 square feet of post-processing and lab space, along with the opportunity for a joint venture with a commercial kitchen space of 1,100 square feet. The remainder of the building is ancillary rooms such as water rooms, offices, locker rooms, and break rooms.
"Nevada is a rapidly growing adult-use cannabis market that shows no sign of slowing down," said the CEO of Item 9 Labs Corp. Andrew Bowden. According to MJ Brand Insights, the state brought in $1.03 billion in taxable sales between adult-use and medical cannabis dispensaries in the 2021 fiscal year, which was a $318 million increase from the previous year.
He continued, "We are optimistic about the potential opportunities we have to expand alongside the booming cannabis industry in Nevada."
For more information:
Item 9 Labs Corp.